Metastatic basal cell carcinoma with neuroendocrine differentiation. Complete response to cemiplimab. Marti-Marti I, Puig S, Albero-Gonzalez R, Masferrer E, et al. Clin Exp Dermatol 2024 Mar 18:llae099. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Marti-Marti I, Puig S, Albero-Gonzalez R, Masferrer E, et al. Metastatic basal cell carcinoma with neuroendocrine differentiation. Complete response to cemiplimab. Clin Exp Dermatol 2024 Mar 18:llae099. doi: 10.1093.
PMID: 38494790